Details

---

Manufacturer
OTSUKA PHARMACEUTICAL CO., LTD(JAPAN)
Registraction Number
MAL24086003AZ

Contents

Active Ingredient: Delamanid, 50 mg per tablet.
Excipients: Includes lactose monohydrate and other inactive ingredients.

Indications

Deltyba is used for:
Treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) as part of an appropriate combination regimen
It is prescribed when other treatment options are limited due to resistance or tolerability issues.

Instructions

Dosage:
Adults: 100 mg (two tablets) twice daily for 24 weeks.
Adolescents and children: Dosage varies based on body weight and is determined by a healthcare professional.
Administration: Take orally with food to enhance absorption.
Precautions:
Regular monitoring of heart function (ECG) is recommended due to potential QT prolongation.
Avoid use if allergic to delamanid or any of its ingredients.
Consult a doctor if pregnant, breastfeeding, or taking other medications.
Storage: Store below 30°C and protect from light.